Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andrew H Limper

Showing results (41-50 of 231) with videos related to

Pageof 24
Sort By:
Infection|February 22, 2017
Pulmonary mucormycosis: clinical features and outcomesErica Lin, Teng Moua, Andrew H Limper
Frontiers in Immunology|January 3, 2022
Current State of Carbohydrate Recognition and C-Type Lectin Receptors in <i>Pneumocystis</i> Innate ImmunityTheodore J Kottom, Eva M Carmona, Andrew H Limper
FEMS Yeast Research|June 14, 2015
Pathobiology of Pneumocystis pneumonia: life cycle, cell wall and cell signal transductionJoseph H Skalski, Theodore J Kottom, Andrew H Limper
Infection and Immunity|August 23, 2003
Evidence for a melanin cell wall component in Pneumocystis cariniiCrystal R Icenhour, Theodore J Kottom, Andrew H Limper
The Journal of Eukaryotic Microbiology|January 23, 2004
Melanin-like pigments in Pneumocystis cariniiCrystal R Icenhour, Theodore J Kottom, Andrew H Limper
Infection and Immunity|November 7, 2007
Pneumocystis carinii exhibits a conserved meiotic control pathwayJoshua W Burgess, Theodore J Kottom, Andrew H Limper
Clinics in Chest Medicine|April 21, 2009
Pneumocystis pneumonia: current concepts in pathogenesis, diagnosis, and treatmentBryan J Krajicek, Charles F Thomas, Andrew H Limper
Journal of Medical Microbiology|March 23, 2026
Functional and molecular characterization of <i>Aspergillus fumigatus</i> phosphoglucomutase (<i>Pgm</i>): a potential target for antifungal therapyConrad C Achilonu, Theodore J Kottom, Andrew H Limper
Expert Review of Respiratory Medicine|April 16, 2020
Advances in the diagnosis of fungal pneumoniasBryan T Kelly, Kelly M Pennington, Andrew H Limper
Antimicrobial Agents and Chemotherapy|August 26, 2020
Targeting CARD9 with Small-Molecule Therapeutics Inhibits Innate Immune Signaling and Inflammatory Response to Pneumocystis carinii β-GlucansTheodore J Kottom, Eva M Carmona, Andrew H Limper
Pageof 24

Showing results (41-50 of 231) with videos related to

Sort By:
Pageof 24
Infection|February 22, 2017
Pulmonary mucormycosis: clinical features and outcomesErica Lin, Teng Moua, Andrew H Limper
Frontiers in Immunology|January 3, 2022
Current State of Carbohydrate Recognition and C-Type Lectin Receptors in <i>Pneumocystis</i> Innate ImmunityTheodore J Kottom, Eva M Carmona, Andrew H Limper
FEMS Yeast Research|June 14, 2015
Pathobiology of Pneumocystis pneumonia: life cycle, cell wall and cell signal transductionJoseph H Skalski, Theodore J Kottom, Andrew H Limper
Infection and Immunity|August 23, 2003
Evidence for a melanin cell wall component in Pneumocystis cariniiCrystal R Icenhour, Theodore J Kottom, Andrew H Limper
The Journal of Eukaryotic Microbiology|January 23, 2004
Melanin-like pigments in Pneumocystis cariniiCrystal R Icenhour, Theodore J Kottom, Andrew H Limper
Infection and Immunity|November 7, 2007
Pneumocystis carinii exhibits a conserved meiotic control pathwayJoshua W Burgess, Theodore J Kottom, Andrew H Limper
Clinics in Chest Medicine|April 21, 2009
Pneumocystis pneumonia: current concepts in pathogenesis, diagnosis, and treatmentBryan J Krajicek, Charles F Thomas, Andrew H Limper
Journal of Medical Microbiology|March 23, 2026
Functional and molecular characterization of <i>Aspergillus fumigatus</i> phosphoglucomutase (<i>Pgm</i>): a potential target for antifungal therapyConrad C Achilonu, Theodore J Kottom, Andrew H Limper
Expert Review of Respiratory Medicine|April 16, 2020
Advances in the diagnosis of fungal pneumoniasBryan T Kelly, Kelly M Pennington, Andrew H Limper
Antimicrobial Agents and Chemotherapy|August 26, 2020
Targeting CARD9 with Small-Molecule Therapeutics Inhibits Innate Immune Signaling and Inflammatory Response to Pneumocystis carinii β-GlucansTheodore J Kottom, Eva M Carmona, Andrew H Limper
Pageof 24